18:05 GMT20 April 2021
Listen Live
    Get short URL
    0 23

    At least 80 healthy adult volunteers are expected to participate in the early-stage clinical trial.

    WASHINGTON (Sputnik) – US allergy and disease institutes launched human clinical trials of an investigational Zika virus vaccine developed earlier this year, the National Institutes of Health (NIH) said in a press release on Wednesday.

    "NIAID [National Institute of Allergy and Infectious Diseases] worked expeditiously to ready a vaccine candidate, and results in animal testing have been very encouraging. We are pleased that we are now able to proceed with this initial study in people," NIAID Director Anthony Fauci stated.

    The study is intended to evaluate the vaccine’s safety and ability to generate an immune system response, according to the NIH. At least 80 healthy adult volunteers are expected to participate in the early-stage clinical trial.

    More than 6,400 Zika cases have been reported in the United States and US territories.

    The US Centers for Disease Control and Prevention (CDC) activated an emergency response team to the city of Miami, Florida after Governor Rick Scott announced the discovery of 14 new Zika cases in the state since Friday.

    The current Zika outbreak started in Brazil in the spring of 2015. The virus is transmitted by daytime-active mosquitoes. While the Zika virus does not cause serious complications in adults, it can cause severe brain defects and microcephaly in newborns.


    Most US Citizens Are Not Afraid of Catching Zika Virus, a Poll Reveals
    New York City to Fight Zika Virus in Subway System
    Number of Zika-Infected People in Mexico Soars by Almost 500 in 19 Days
    Zika-Carrying Mosquitoes Might Be Resistant to Insecticide Used in Miami
    vaccine, Zika Virus, US National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), US
    Community standardsDiscussion